TY - JOUR
T1 - The next generation of risk assessment multi-year study–highlights of findings, applications to risk assessment, and future directions
AU - Cote, Ila
AU - Andersen, Melvin E.
AU - Ankley, Gerald T.
AU - Barone, Stanley
AU - Birnbaum, Linda S.
AU - Boekelheide, Kim
AU - Bois, Frederic Y.
AU - Burgoon, Lyle D.
AU - Chiu, Weihsueh A.
AU - Crawford-Brown, Douglas
AU - Crofton, Kevin M.
AU - Devito, Michael
AU - Devlin, Robert B.
AU - Edwards, Stephen W.
AU - Guyton, Kathryn Z.
AU - Hattis, Dale
AU - Judson, Richard S.
AU - Knight, Derek
AU - Krewski, Daniel
AU - Lambert, Jason
AU - Maull, Elizabeth Anne
AU - Mendrick, Donna
AU - Paoli, Gregory M.
AU - Patel, Chirag Jagdish
AU - Perkins, Edward J.
AU - Poje, Gerald
AU - Portier, Christopher J.
AU - Rusyn, Ivan
AU - Schulte, Paul A.
AU - Simeonov, Anton
AU - Smith, Martyn T.
AU - Thayer, Kristina A.
AU - Thomas, Russell S.
AU - Thomas, Reuben
AU - Tice, Raymond R.
AU - Vandenberg, John J.
AU - Villeneuve, Daniel L.
AU - Wesselkamper, Scott
AU - Whelan, Maurice
AU - Whittaker, Christine
AU - White, Ronald
AU - Xia, Menghang
AU - Yauk, Carole
AU - Zeise, Lauren
AU - Zhao, Jay
AU - Dewoskin, Robert S.
N1 - Funding Information:
The views in this article are solely those of the authors and do not necessarily reflect the views or policies of their agencies or institutes including (but not limited to) the U.S. EPA, U.S. Food and Drug Administration (FDA), National Institute for Environmental Health Sciences (NIEHS), National Institute for Occupational Safety and Health (NIOSH), California EPA Office of Environmental Health Hazard Assessment (OEHHA), or European Chemicals Agency
Publisher Copyright:
© 2016, Public Health Services, US Dept of Health and Human Services. All rights reserved.
PY - 2016/11
Y1 - 2016/11
N2 - Background: The Next Generation (NexGen) of Risk Assessment effort is a multi-year collaboration among several organizations evaluating new, potentially more efficient molecular, computational, and systems biology approaches to risk assessment. This article summarizes our findings, suggests applications to risk assessment, and identifies strategic research directions. Objective: Our specific objectives were to test whether advanced biological data and methods could better inform our understanding of public health risks posed by environmental exposures. Methods: New data and methods were applied and evaluated for use in hazard identification and dose-response assessment. Biomarkers of exposure and effect, and risk characterization were also examined. Consideration was given to various decision contexts with increasing regulatory and public health impacts. Data types included transcriptomics, genomics, and proteomics. Methods included molecular epidemiology and clinical studies, bioinformatic knowledge mining, pathway and network analyses, short-duration in vivo and in vitro bioassays, and quantitative structure activity relationship modeling. Discussion: NexGen has advanced our ability to apply new science by more rapidly identifying chemicals and exposures of potential concern, helping characterize mechanisms of action that influence conclusions about causality, exposure-response relationships, susceptibility and cumulative risk, and by elucidating new biomarkers of exposure and effects. Additionally, NexGen has fostered extensive discussion among risk scientists and managers and improved confidence in interpreting and applying new data streams. Conclusions: While considerable uncertainties remain, thoughtful application of new knowledge to risk assessment appears reasonable for augmenting major scope assessments, forming the basis for or augmenting limited scope assessments, and for prioritization and screening of very data limited chemicals.
AB - Background: The Next Generation (NexGen) of Risk Assessment effort is a multi-year collaboration among several organizations evaluating new, potentially more efficient molecular, computational, and systems biology approaches to risk assessment. This article summarizes our findings, suggests applications to risk assessment, and identifies strategic research directions. Objective: Our specific objectives were to test whether advanced biological data and methods could better inform our understanding of public health risks posed by environmental exposures. Methods: New data and methods were applied and evaluated for use in hazard identification and dose-response assessment. Biomarkers of exposure and effect, and risk characterization were also examined. Consideration was given to various decision contexts with increasing regulatory and public health impacts. Data types included transcriptomics, genomics, and proteomics. Methods included molecular epidemiology and clinical studies, bioinformatic knowledge mining, pathway and network analyses, short-duration in vivo and in vitro bioassays, and quantitative structure activity relationship modeling. Discussion: NexGen has advanced our ability to apply new science by more rapidly identifying chemicals and exposures of potential concern, helping characterize mechanisms of action that influence conclusions about causality, exposure-response relationships, susceptibility and cumulative risk, and by elucidating new biomarkers of exposure and effects. Additionally, NexGen has fostered extensive discussion among risk scientists and managers and improved confidence in interpreting and applying new data streams. Conclusions: While considerable uncertainties remain, thoughtful application of new knowledge to risk assessment appears reasonable for augmenting major scope assessments, forming the basis for or augmenting limited scope assessments, and for prioritization and screening of very data limited chemicals.
UR - http://www.scopus.com/inward/record.url?scp=84994383204&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84994383204&partnerID=8YFLogxK
U2 - 10.1289/EHP233
DO - 10.1289/EHP233
M3 - Review article
C2 - 27091369
AN - SCOPUS:84994383204
SN - 0091-6765
VL - 124
SP - 1671
EP - 1682
JO - Environmental health perspectives
JF - Environmental health perspectives
IS - 11
ER -